Long-term use of the blood thinner Plavix (clopidogrel) does not increase the overall risk of death in patients who have or are at risk for heart disease, nor are they at increased risk of cancer or death from cancer, according to a Food and Drug Administration (FDA) Safety Advisory. The announcement comes after an agency review of several long-term clinical trials evaluating rates of death, death from cancer, or cancer reported as adverse events. The FDA performed the meta-analyses of long-term clinical trials to assess the effects of Plavix on death rates from all causes. The results showed that long-term, ... Read More
Righting Injustice is published by the Beasley Allen Law Firm. If you are interested in a free legal consultation, please take a few moments to fill out the contact form with as many details as possible. The more information you provide us, the better we can evaluate your claim.